title: Randomized controlled trial of mefenamic acid vs paracervical block for relief of pain for outpatient uterine curettage.
abstract: OBJECTIVE
  To compare the efficacy of mefenamic acid vs paracervical block for pain relief during and after fractional curettage.
  
  
  METHODS
  Between January 1 and July 31, 2002, the authors enrolled 87 patients with abnormal uterine bleeding, who requested fractional curettage at the Outpatient Gynecologic Clinic, Srinagarind Hospital, Khon Kaen University. A simple randomization procedure was used to distribute the patients into a control group comprising 44 patients given a paracervical block and a treatment group comprising 43 patients given mefenamic acid (500 mg) 2 hours before starting the procedure.
  
  
  METHODS
  Pain was scored using a visual analogue scale (VAS range, 0 to 10).
  
  
  RESULTS
  The median pain scores of the treatment types during endocervical, endometrial, immediately after, and 30 minutes after, fractional curettage were 2.5 vs 3.0 (p = 0.42), 6.5 vs 7.5 (p = 0.19), 4.0 vs 3.5 (p = 0.20) and 1.5 vs 1.0 (p = 0.17), respectively. The rate of complications was 6.8% (3 in 44) in the paracervical lignocaine injection group.
  
  
  CONCLUSIONS
  The efficacy of pain relief for fractional curettage using oral mefenamic acid (500 mg) two hours before the procedure was not statistically different from the paracervical block, but there were fewer side effects. Mefenamic acid should be considered an alternate pain relief during fractional curettage.
authors.affiliation: Department of OB-GYN, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002 Thailand. pranomcme@yahoo.com
authors.forename: Pranom
authors.initials: P
authors.lastname: Buppasiri
authors.forename: Saowanee
authors.initials: S
authors.lastname: Tangmanowutikul
authors.forename: Wilaiwan
authors.initials: W
authors.lastname: Yoosuk
mesh_terms: D000773:Anesthesia, Obstetrical; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D004107:Dilatation and Curettage / Q000009:adverse effects / Q000379:methods*; D005260:Female; D006801:Humans; D008528:Mefenamic Acid / Q000627:therapeutic use*; D010146:Pain / Q000209:etiology / Q000517:prevention & control*; D010147:Pain Measurement; D016896:Treatment Outcome; D014592:Uterine Hemorrhage / Q000517:prevention & control*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D008528:Mefenamic Acid